Search for: "Senator Thom Tillis" Results 181 - 200 of 547
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2022, 9:15 am by Eileen McDermott
In January of this year, Senator Thom Tillis (R-NC) sent a letter to Matthew Wiener, Acting Chairman of the Administrative Conference of the United States (ACUS), and Todd Rubin, ACUS Counsel for Congressional Affairs, asking that the ACUS “conduct a study on whether Congress should create a unified, stand-alone, and independent Intellectual Property Office. [read post]
15 Mar 2022, 9:15 am by Eileen McDermott
In January of this year, Senator Thom Tillis (R-NC) sent a letter to Matthew Wiener, Acting Chairman of the Administrative Conference of the United States (ACUS), and Todd Rubin, ACUS Counsel for Congressional Affairs, asking that the ACUS “conduct a study on whether Congress should create a unified, stand-alone, and independent Intellectual Property Office. [read post]
10 Mar 2022, 10:15 am by Eileen McDermott
Senators Thom Tillis (R-NC), Chris Coons (D-DE), Tom Cotton (R-AR), Mazie Hirono (D-HI), and Rick Scott (R-FL) introduced the bill on March 8. [read post]
10 Mar 2022, 10:15 am by Eileen McDermott
Senators Thom Tillis (R-NC), Chris Coons (D-DE), Tom Cotton (R-AR), Mazie Hirono (D-HI), and Rick Scott (R-FL) introduced the bill on March 8. [read post]
9 Mar 2022, 11:33 am by Eileen McDermott
The Initiative for Medicines, Access & Knowledge (I-MAK) has responded to a letter it received from Senator Thom Tillis (R-NC) in January asking the organization to address claims that its data on the effects of pharmaceutical patents on drug pricing is faulty. [read post]
9 Mar 2022, 11:33 am by Eileen McDermott
The Initiative for Medicines, Access & Knowledge (I-MAK) has responded to a letter it received from Senator Thom Tillis (R-NC) in January asking the organization to address claims that its data on the effects of pharmaceutical patents on drug pricing is faulty. [read post]
9 Mar 2022, 7:37 am by John Jascob
Jon Tester (D-Mont), Thom Tillis (R-NC), Sherrod Brown (D-Ohio)—Chair of the Senate Banking Committee—and Ranking Member Patrick Toomey (R-Pa), said in a press release that the bill comes with a sense of urgency as the 2023 end-date for LIBOR fast approaches and uncertainties remain about the potential for litigation over some legacy contracts.The bill’s sponsors cited in their press release a letter from 23 banking and securities industry participants in… [read post]
3 Mar 2022, 12:15 pm by Eileen McDermott
In December, Senator Thom Tillis (R-NC) wrote a letter to President Biden asking Biden to withdraw Sohn’s nomination, explaining that her role as a co-founder of the open Internet advocacy group Public Knowledge poses a threat to copyright owners in particular. [read post]
25 Feb 2022, 5:22 pm by Ellena Erskine
Other statements from Judiciary Committee members: Cory Booker, D-N.J.; Chris Coons, D-Del.; Diane Feinstein, D-Cal.; Mazie Hirono, D-Hawaii; Amy Klobuchar, D-Minn.; Patrick Leahy, D-Vt.; Jon Ossoff, D-Ga.; John Cornyn, R-Texas; Josh Hawley, R-Mo.; John Kennedy, R-La.; Mike Lee, R-Utah; Ben Sasse, R-Neb.; and Thom Tillis, R-N.C. [read post]
13 Feb 2022, 9:15 am by Kirk Hartung
North Carolina Republican Senator Thom Tillis has raised the possibility of a combined patent, trademark and copyright office so as to improve the federal government’s approach to all aspects of intellectual property. [read post]
13 Feb 2022, 9:15 am by Kirk Hartung
North Carolina Republican Senator Thom Tillis has raised the possibility of a combined patent, trademark and copyright office so as to improve the federal government’s approach to all aspects of intellectual property. [read post]
6 Feb 2022, 8:26 pm by Patent Docs
Thom Tillis (R-NC), the Ranking Member of the Subcommittee on Intellectual Property of the Senate Committee of the Judiciary, wrote to the Administrative Conference of the United States (ACUS) to request that the agency "conduct a study on whether Congress should create a unified, stand-alone, and independent Intellectual Property Office. [read post]
3 Feb 2022, 10:23 am by Eileen McDermott
On February 3, during an Executive Business Meeting of the Senate Judiciary Committee, Senator Thom Tillis (R-NC) proposed several amendments on the markup of S. 2710, the Open App Markets Act. [read post]
3 Feb 2022, 10:23 am by Eileen McDermott
On February 3, during an Executive Business Meeting of the Senate Judiciary Committee, Senator Thom Tillis (R-NC) proposed several amendments on the markup of S. 2710, the Open App Markets Act. [read post]
1 Feb 2022, 10:03 am by Eileen McDermott
Now, Senator Thom Tillis (R-NC) has written letters to the key organization providing that data, the Initiative for Medicines, Access & Knowledge (I-MAK), as well as the Food and Drug Administration (FDA) and the U.S. [read post]
1 Feb 2022, 10:03 am by Eileen McDermott
Now, Senator Thom Tillis (R-NC) has written letters to the key organization providing that data, the Initiative for Medicines, Access & Knowledge (I-MAK), as well as the Food and Drug... [read post]
1 Feb 2022, 6:48 am by Jason Rantanen
In response to various calls for “reform” of patent eligibility jurisprudence, on March 5, 2021, Senators Thom Tillis (R-NC), Mazie Hirono (D-HI), Tom Cotton (R-AR), and Christopher Coons (D-DE) requested that the US Patent and Trademark Office (PTO) conduct a study regarding public views on “how the current jurisprudence has adversely impacted investment and innovation in critical technologies like quantum computing, artificial intelligence, precision… [read post]